3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pain, Postoperative
19
Breast Neoplasms
16
Pain
8
Agnosia
8
Lung Neoplasms
6
Prostatic Neoplasms
5
Neoplasms
5
Stomach Neoplasms
4
Colorectal Neoplasms
4
Colonic Neoplasms
3
Supratentorial Neoplasms
2
Postoperative Complications
2
Meningioma
2
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Sleep Deprivation
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Pain, Intractable
1
Ovarian Cysts
1
Oropharyngeal Neoplasms
1
Neuroblastoma
1
Neoplasm Metastasis
1
Malignant Neoplasms of Male Genital Organs
1
Liver Neoplasms
1
Liver Diseases
1
Leiomyoma
1
Kidney Neoplasms
1
Intraoperative Complications
1
Interventions
Propofol
4
Saline Solution
3
Dexmedetomidine
3
remimazolam
2
Sugammadex
1
Sufentanil
1
Sodium Chloride
1
Ropivacaine
1
Pyridostigmine Bromide
1
Neuroleptanalgesia
1
Nalbuphine
1
Minocycline
1
Midazolam
1
Methylene Blue
1
Ketamine
1
Injections
1
Ibuprofen
1
Duloxetine Hydrochloride
1
Control Groups
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Emergence Delirium
×
Ropivacaine
×
Clear all
NCT05596071
2022-10-27
POD
Zhejiang Cancer Hospital
Phase NA
Completed
130 enrolled